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RESEARCH
Validation of Plasmodium falciparum 
dUTPase as the target of 5′‑tritylated 
deoxyuridine analogues with anti‑malarial 
activity
Guiomar Pérez‑Moreno1†, Paula Sánchez‑Carrasco1†, Luis Miguel Ruiz‑Pérez1, Nils Gunnar Johansson2, 
Sylke Müller3, Beatriz Baragaña4, Shahienaz Emma Hampton4, Ian Hugh Gilbert4, Marcel Kaiser5,6, 
Sandipan Sarkar7, Thiyagamurthy Pandurangan7, Vijeesh Kumar7 and Dolores González‑Pacanowska1* 
Abstract 
Background: Malaria remains as a major global problem, being one of the infectious diseases that engender highest 
mortality across the world. Due to the appearance of resistance and the lack of an effective vaccine, the search of 
novel anti‑malarials is required. Deoxyuridine 5′‑triphosphate nucleotido‑hydrolase (dUTPase) is responsible for the 
hydrolysis of dUTP to dUMP within the parasite and has been proposed as an essential step in pyrimidine metabolism 
by providing dUMP for thymidylate biosynthesis. In this work, efforts to validate dUTPase as a drug target in Plasmo-
dium falciparum are reported.
Methods: To investigate the role of PfdUTPase in cell survival different strategies to generate knockout mutants were 
used. For validation of PfdUTPase as the intracellular target of four inhibitors of the enzyme, mutants overexpressing 
PfdUTPase and HsdUTPase were created and the IC50 for each cell line with each compound was determined. The 
effect of these compounds on dUTP and dTTP levels from P. falciparum was measured using a DNA polymerase assay. 
Detailed localization studies by indirect immunofluorescence microscopy and live cell imaging were also performed 
using a cell line overexpressing a Pfdut‑GFP fusion protein.
Results: Different attempts of disruption of the dut gene of P. falciparum were unsuccessful while a 3′ replacement 
construct could recombine correctly in the locus suggesting that the enzyme is essential. The four 5′‑tritylated deox‑
yuridine analogues described are potent inhibitors of the P. falciparum dUTPase and exhibit antiplasmodial activity. 
Overexpression of the Plasmodium and human enzymes conferred resistance against selective compounds, providing 
chemical validation of the target and confirming that indeed dUTPase inhibition is involved in anti‑malarial activity. In 
addition, incubation with these inhibitors was associated with a depletion of the dTTP pool corroborating the central 
role of dUTPase in dTTP synthesis. PfdUTPase is mainly localized in the cytosol.
Conclusion: These results strongly confirm the pivotal and essential role of dUTPase in pyrimidine biosynthesis of P. 
falciparum intraerythrocytic stages.
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provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
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Background
Malaria, with approximately 216 million cases each year 
and more than 445,000 attributed deaths reported annu-
ally, remains a devastating global health problem. The 
disease in humans is caused by the infection of 5 differ-
ent Plasmodium species, among which Plasmodium fal-
ciparum causes most mortality, mainly in children below 
the age of 5 [1]. Because of the appearance of resistance 
to the current anti-malarial drugs and the absence of an 
effective vaccine, there is an urgent need for new drugs to 
treat the disease.
The biosynthesis of nucleotides has been highlighted as 
a promising pathway in the search for new anti-malarial 
targets, due to the high dependence of nucleotides in 
the intraerythrocytic stages [2]. Certain enzymes, such 
as dihydroorotate dehydrogenase or purine nucleoside 
phosphorylase, have been extensively studied as drug 
targets yet the potential of other steps of the pathway 
remains unclear [3, 4].
New anti-malarial strategies have included evaluation 
of the enzyme dUTPase (deoxyuridine 5′-triphosphate 
nucleotidohydrolase, E.C. 3.6.1.23) as a potential drug 
target. This enzyme is essential in both eukaryotes [5] and 
prokaryotes [6] and several inhibitors of the enzyme have 
been described that exhibit anti-malarial activity [7–10] 
although for certain derivatives the correlation between 
dUTPase inhibition and anti-malarial activity was poor. 
dUTPase performs a dual role by catalyzing the hydroly-
sis of dUTP to dUMP and PPi. It supplies the dUMP sub-
strate for dTMP synthesis, as well as minimizes cellular 
levels of dUTP, avoiding misincorporation in DNA [11], 
which might otherwise be incorporated into DNA during 
replication giving rise to an activation of the base exci-
sion repair pathway and multiple cellular defects [11]. 
Several different oligomeric forms of the enzyme exist in 
nature, including monomers, dimers and trimers. Plas-
modium falciparum and human cells contain a trimeric 
form of the enzyme yet selective inhibition is achievable. 
The trimeric dUTPases possess five highly conserved 
sequence motifs which participate in the active site and 
provide residues which are essential for activity [12]. The 
crystal structures of different dUTPases including the P. 
falciparum and human enzymes have been published to 
date [13, 14] and the molecular and structural basis for 
the specific inhibition of a series of triphenyl uridine 
derivatives has been established [13].
While dUTPase has been extensively studied with 
the aim of inhibitor discovery, little information exists 
regarding its biological role and essentiality for cell sur-
vival in P. falciparum. A recent study performed in 
Plasmodium berghei has suggested that dUTPase null 
mutants are not viable [15]. It is reasonable to assume 
that dUTPase is crucial to the parasite given the high AT/
CG ratio (approximately 80%) in its genome and the fact 
that Plasmodium lacks dCMP/dCTP deaminase activities 
which would confer a central role to dUTPase in dUMP 
formation.
In this paper, efforts to perform gene disruption stud-
ies of the dut gene and to address chemical target vali-
dation of dUTPase inhibitors are described. The results 
suggest that the enzyme is essential for the proliferation 
of intraerythrocytic stage of Plasmodium falciparum and 
that dUTPase indeed is the target for certain inhibitors 
of the enzyme with anti-malarial activity. Detailed locali-
zation studies using different approaches have been also 
performed, and show that the enzyme has a ubiquitous 
intracellular localization appearing in cytosol, nuclei and 
mitochondria.
Methods
Chemistry
Synthesis and analytical characterization of compounds 
1–4 is contained in Additional file 1.
Plasmid design and construction
The Pfdut coding sequence previously isolated [13] was 
used as template for PCR to obtain the construct pHH1-
dutKO. A 383 bp fragment was amplified for the KO con-
struct, where a start codon (bold faced) at position 94 of 
the Pfdut open reading frame (motif 1) and a premature 
STOP codon (bold faced) at position 477 (motif 5) were 
introduced into the oligonucleotide. The 5′ primer AGA 
TCT ATG TTT ATT GTA AAA GATGA contains a BglII 
restriction site (underlined) and the 3′ primer CTC GAG 
TCA GGA AGT TTC ATC CAG TTC a XhoI restriction 
site (underlined) to allow directional cloning into the pre-
viously digested transfection plasmid pHH1 (5766  bp). 
For the KOkon construct, a 423 bp fragment of the Pfdut 
coding sequence lacking 93  bp at the 5′ region (GCGC 
AGA TCT ATT GTA AAA GAT GAA GTA CTG), but retain-
ing the 3′ terminus of the Pfdut gene (CGCG CTC GAG 
TCA ATA TTT ATT ATT CGA TGT ) was cloned into 
pHH1.
The human dut coding sequence (497  bp) was ampli-
fied with the oligonucleotides GCGC AGA TCT ATG CCC 
TGC TCT GAA GAG and GCGC GCG GCC GCTTA ATT 
Keywords: Plasmodium falciparum, Deoxyuridine 5′‑triphosphate nucleotido‑hydrolase, 5′‑tritylated deoxyuridine 
analogues, Mode of action
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CTT TCC AGT GAA ACC , which introduced BglII and 
NotI restriction sites (underlined) that allowed the direc-
tional cloning into the expression vector pHrBl. The cod-
ing sequence for human dUTPase (HsdUTPase) cloned 
in the pGEM-T vector was used as template for PCR 
amplification. It was also used as template for the ampli-
fication and subsequent cloning of Hsdut pHH2, replac-
ing the green fluorescent protein (GFP) coding sequence 
present in the original plasmid. The specific oligonucleo-
tides AGA TCT ATG CCC TGC TCT GAA GAG and CTG 
CAG TTA ATT CTT TCC AGT GG, containing the BglII 
and PstI restriction sites, respectively, were used for the 
amplification.
For the construct pHH2-Pfdut, the 524  bp fragment 
of the Pfdut coding sequence was amplified with the 
oligonucleotides AGA TCT ATG CAT TTA AAA ATT 
GTATG and CTG CAG TCA ATA TTT ATT ATT CGATG. 
The sense oligonucleotide contains a BglII restriction 
site (underlined), and the antisense oligonucleotide con-
tains a PstI site (underlined) to allow directional cloning 
into the previously digested transfection plasmid pHH2 
(6540  bp). The Pfdut gene was also amplified with the 
oligonucleotides AGA TCT ATG CAT TTA AAA ATT and 
CCT AGG ATA TTT ATT ATT CGA by PCR avoiding the 
STOP codon and cloned in pHH2 maintaining the GFP 
coding sequence to obtain the construct pHH2-Pfdut-
GFP that allows for expression of PfdUTPase fused to 
GFP in transfected Plasmodium parasites.
The pHH1 and pHH2 series of plasmids contain a 
human DHFR fragment mutated to encode resistance 
to WR99210 which allow the selection of transfected 
parasites while pHrBl contains the blasticidine resistance 
gene. All PCR products were first cloned into pGEM-T 
(Invitrogen), where the sequences were verified, and then 
subcloned into the appropriate vectors.
Plasmodium falciparum cultures and transfection
Plasmodium falciparum asexual erythrocytic-stage 
parasites (3D7, a cloned line derived from isolate NF54) 
were cultured at 37 °C, 5%  CO2 in 5% haematocrit using 
human O-positive erythrocytes and fed every day with 
complete culture medium (RPMI 1640 (Gibco) supple-
mented with 0.2%  NaHCO3, 0.15  mM hypoxanthine, 
12.5  μg/ml gentamycin (Gibco), 2% heat inactivated 
human serum, and 0.5% Albumax II (Gibco) [16]. Syn-
chronized ring-stage parasites (~ 5% parasitaemia) with 
5% sorbitol, were transfected with 100 μg of circular puri-
fied plasmid DNA (HiSpeed plasmid maxi kit; Qiagen) 
in a Genepulser from BioRad, and drug cycling com-
menced according to methodology described previously 
by Crabb et al. [17]. Following transfection, the samples 
were immediately mixed with 10 ml culture medium and 
cultured in 25-cm2 culture flasks until 5% parasitaemia 
for 48 h prior to selection with 5 nM WR99210 (Jacobus 
Pharmaceuticals). The parasites were maintained under 
drug pressure for 5  days and then the concentration of 
drug was decreased to 2.5 nM WR99210. The first para-
sites were observed after 25–28 days of selection in con-
tinuous culture. Drug cycling was performed in order to 
select for homologous recombination of the constructs 
and loss of episomal DNA. For this purpose, transfect-
ants were cultured for 3 weeks without drug pressure fol-
lowed by 4 days with WR99210 pressure. This selection 
cycle was repeated for several rounds, and at different 
stages parasite DNA was isolated and subjected to South-
ern blotting and PCR analyses to determine whether epi-
somal DNA was present and if integration into the Pfdut 
gene locus had occurred.
Southern blot analysis
Parasitized erythrocytes (5 × 108 parasites per sample) 
were harvested by centrifugation, treated with 1.5 vol-
umes of saponin 0.15% in PBS for 5 min at 4 °C and after 
adding another 5 volumes of PBS, cells were centrifuged 
at 5000 rpm for 10 min. Genomic DNA was isolated from 
parasite pellets using the QIAamp DNA Mini Kit (Qia-
gen). Manipulation of recombinant DNA and analysis of 
nucleic acids by Southern blot hybridization were carried 
out using standard procedures [18].
In vitro assays
In vitro inhibitory activity against the erythrocytic 
stages of P. falciparum of overexpressing mutants was 
determined by using the SYBR green assay [19] and 
the 3H-hypoxanthine incorporation assay was used for 
IC50 determination as previously described [8]. Plas-
modium falciparum 3D7 was cultured using standard 
methods, and synchronized using 5% sorbitol as pre-
viously described [20]. Compounds were dissolved in 
DMSO and added at different concentrations (8–500 ng/
ml) to 48 h post-synchronization parasites. The content 
in DMSO did not exceed 0.001% to avoid solvent toxic-
ity. Chloroquine dissolved in water was used as standard 
drug. Experiments were carried out at least twice inde-
pendently and the different concentrations were tested 
in duplicate. IC50 values were calculated using a four-
parameter logistic regression model using data obtained 
from two or three independent experiments as indicated.
Measurement of intracellular uridine and thymidine 
nucleotides
The effect of different dUTPase inhibitors on dUTP 
and dTTP levels from P. falciparum cells was meas-
ured using a modified DNA polymerase assay [21]. The 
template sequence employed was the oligonucleotide 
5′-TTT ATT TAT TTA TTT ATT TAG GCG GTG GAG 
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GCGG-3′ and as primer sequence the oligonucleo-
tide 5′-CCG CCT CCA CCG CC-3′ was used. Saponin-
isolated parasite pellets (5 × 108 parasites per sample) 
were repeatedly washed in PBS and frozen at − 80  °C. 
Frozen pellets were extracted with 200 μl of cold meth-
anol/water (1:1, v/v) vigorously by vortexing, freeze-
thawed twice and centrifuged. Supernatants were 
collected and pellets were re-extracted with the same 
volume of methanol/water as previously mentioned 
and newly centrifuged. The combined supernatants 
were dried under vacuum. The residues were dissolved 
in 40  μl either of dUTPase buffer (34  mM Tris–HCl 
pH 7.8, 5  mM  MgCl2) or dUTPase buffer plus 30  ng 
of HsdUTPase and incubated for 20  min at 37  °C. To 
stop the reaction, 60 μl of 100% methanol were added 
and the samples were incubated for 1 h at − 20 °C, fol-
lowed by centrifugation for 20  min at 16,000×g. The 
supernatants were again dried under vacuum and the 
DNA polymerase assay used was modified from that 
of Horowitz et  al. [21]. The DNA polymerase I buffer 
contained 34 mM Tris–HCl pH 7.8, and 50 mM  MgCl2. 
After incubation with DNA polymerase I, 30 μl of each 
sample were incubated for 30 min at 4 °C with 470 μl of 
DNA polymerase I buffer containing 10% (v/v) trichlo-
roacetic acid to precipitate the DNA. The solution was 
blotted onto a glass microfibre filter GF/C (Whatman) 
and each filter was washed under vacuum with 30  ml 
of a solution of 5% (v/v) trichloroacetic acid and 3 ml of 
ethanol, dried and the radioactivity was counted using 
a LS 6500 Multi-Purpose Scintillation Counter (Beck-
man Coulter).
Generation of antibodies against HsdUTPase 
and PfdUTPase and Western blot analysis
Both proteins, PfdUTPase and HsdUTPase were puri-
fied as previously described [10]. Polyclonal antiserum 
against recombinant PfdUTPase and HsdUTPase was 
generated by immunizing rabbits with the purified 
protein. The monoclonal anti-PfdUTPase antibody, 
used for immunofluorescence analysis, was obtained 
as described previously [22]. Protein extracts were 
prepared from saponin-isolated parasites by sonica-
tion. Unless otherwise mentioned, the parasites were 
obtained from cultures of highly synchronized tropho-
zoites. 10  µg of total extract of P.  falciparum proteins 
were subjected to SDS–PAGE, blotted on an Immo-
bilon-P membrane (Millipore) and incubated with 
1:10,000 dilution of the anti-HsdUTPase antibody. 
Bound antibody was detected by reaction with horse-
radish peroxidase (HRP)-conjugate goat anti-rabbit 
IgG (Promega) at a dilution of 1:5000 and an ECL™ 
immunodetection kit (Amersham Pharmacia Biotech). 
Anti-Hsp70 polyclonal antibody (LifeSpan BioSciences) 
was used as loading control (1:10,000 dilution).
Fluorescence microscopy
For indirect immunofluorescence microscopy, 10  ml 
of infected erythrocytes at 5% of parasitaemia were 
washed once in PBS then fixed with 4% paraformalde-
hyde and 0.0075% glutaraldehyde in PBS for 30 min. For 
visualization of the mitochondrion, cells were washed 
once with PBS, resuspended in the same medium con-
taining 50  nM MitoTracker Red CMXRos (Molecular 
Probes), and incubated for 15 min at 37 °C before start-
ing the fixation process. Fixed cells were washed once 
in PBS and then permeabilized with 0.1% Triton X-100/
PBS for 10 min. Cells were washed again in PBS and then 
treated with 0.1 mg/ml of sodium borohydride  (NaBH4)/
PBS for 10 min to reduce any free aldehyde groups. Fol-
lowing another PBS wash, cells were blocked in 3% 
BSA/PBS for 1  h. Indirect immunofluorescence confo-
cal microscopy using an anti-PfdUTPase monoclonal 
antibody or anti-HsdUTPase polyclonal antibody was 
performed in both wild-type cells and in overexpress-
ing mutants. The anti-PfdUTPase monoclonal antibody 
(diluted 1:250) or anti-HsdUTPase polyclonal antibody 
(diluted 1:500) were added and incubated for 1  h. Cells 
were washed three times in PBS for 10 min each. Alexa 
Fluor goat anti-mouse 488 (Molecular Probes) diluted 
1:200 or goat anti-rabbit IgG FITC-conjugate (Sigma) 
diluted 1:40 were added and allowed to bind for 1 h. Cells 
were washed three times in PBS. Cells were finally fixed 
with cold methanol (Merck). Samples were stained with 
 Vectashield®-DAPI (Vector Laboratories) and analysed 
with a Leica TCS SP5 confocal microscopy system. The 
colocalization analysis was performed with the image 
processing software ImageJ.
For live cell imaging, the parasites transfected with 
pHH2-Pfdut-GFP were incubated at 37 °C for 15 min in 
medium containing 100  μg/ml of Hoechst 33342 (Invit-
rogen) and 50  nM of MitoTracker Red CMXRos. After 
washing, cells were pelleted and resuspended in 2 vol-
umes of medium and then mounted to perform micros-
copy. Cells were viewed with a confocal Leica TCS SP5 
microscopy system.
Results
The dut gene is essential for asexual intraerythrocytic 
stages of P. falciparum
To investigate the role of dUTPase in cell survival, the 
deletion of the gene in intraerytrocityc stages of P. falci-
parum was attempted. Different strategies were employed 
to replace the endogenous gene using approaches leading 
to single recombination as described [23, 24]. PCR frag-
ments for single homologous recombination of the dut 
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locus were obtained by PCR and cloned into the vec-
tor pHH1. Figure 1, panels a and b, indicate the strategy 
designed. The pHH1 knockout construct (pHH1-dutKO) 
was truncated at its 5′ end, although an ATG start codon 
was introduced while at the 3′ end a premature STOP 
codon was introduced 237  bp upstream of the natural 
STOP codon. This would result in the formation of two 
incomplete and inactive Pfdut copies upon single cross-
over recombination of the plasmid in the gene locus. 
In contrast, the control construct (pHH1-dutKOkon) 
retains the 3′ region of the dut gene but lacks the 5′ 
region and thus would generate upon recombination a 
functional copy and a non-functional pseudogene. After 
transfection experiments with both constructs, trans-
fected cells were readily obtained in both cases. Trans-
fected parasite lines were taken through several drug 
selection cycles in order to favour/select the population 
of parasites where a single crossover event in the Pfdut 
locus had occurred. Genomic DNA was isolated and 
analysed by diagnostic Southern blotting to establish 
integration events into the parasite genome. In the case 
of pHH1-dutKO, Southern blot revealed the presence of 
endogenous Pfdut (1782  bp band) and linearized plas-
mid (5418  bp band), but no integration events into the 
parasite genome were detected after several drug cycles 
(Fig. 1c). However in the case of transfection with pHH1-
dutKOkon, three rounds of drug removal resulted in the 
integration of the construct, with two new bands of 4985 
and 2217 bp as shown in Fig. 1d.
The expression of a heterologous dut gene in Plasmo-
dium cells that may allow for subsequent removal of the 
endogenous copy of Pfdut was used as a second knockout 
strategy. For this purpose, the trimeric HsdUTPase was 
chosen. The coding sequence of human dut was cloned 
into the expression vector pHrBl to yield pHrBl-Hsdut. 
This construct was cotransfected with pHH1-dutKO and 
cells resistant to blasticidine and to the human DHFR 
inhibitor WR99210 were obtained. The correct expres-
sion of HsdUTPase was tested using a specific anti-
body (Additional file 2a) while correct transfection with 
pHH1-dutKO was verified by Southern blot (Additional 
file 2b). Cells efficiently overexpressed the human enzyme 
and showed a normal growth profile. However, after sev-
eral drug cycles, no integration events were detected by 
Southern blotting. All together these results suggest that, 
although the dut gene is targetable, no insertions are 
favored which may lead to gene disruption.
dUTPase overexpression induces resistance 
against inhibitors with anti‑malarial activity
Four new inhibitors of plasmodial dUTPase were used. 
The structures of the compounds selected together with 
the Ki values for PfdUTPase and HsdUTPase are shown 
in Additional file 1 and Table 1 and are all trityl deriva-
tives containing the uracil base. The IC50 values for 
intraerythrocytic stages of P. falciparum are also indi-
cated. Compounds 1 and 3 contain the ribose ring while 
2 and 4 are acyclic derivatives. These compounds inhibit 
Plasmodium dUTPase while are mostly inactive against 
the human enzyme yet exhibit anti-malarial activity 
in  vitro at nanomolar concentrations. The most potent 
enzyme inhibitor against PfdUTPase was compound 3 
(Ki 79  nM) while compound 1 was the least active (Ki 
4.73 μM). Moreover, compounds 1 and 2 were the most 
active in vitro against the parasite with IC50 values of 40 
and 60 nM respectively.
Evidence that inhibitors were acting on-target in Plas-
modium was first sought for by creating Plasmodium 
mutants overexpressing PfdUTPase and HsdUTPase. 
After transfection, protein overexpression in these cell 
lines was confirmed by Western blot and the localization 
within the cell by immunofluorescence. Indirect inmuno-
fluorescence was performed using anti-PfdUTPase and 
anti-HsdUTPase monoclonal and polyclonal antibodies 
(Fig.  2a). After the quantification of Western blot sig-
nals with ImageQuant software (GE healthcare), it was 
established that the levels of PfdUTPase were around six-
fold higher in the PfdUTPase overexpressing line while 
HsdUTPase although detectable, overexpressed to a 
lesser degree (Fig. 2b).
(See figure on next page.)
Fig. 1 Efforts for disruption of the Pfdut gene by single crossover recombination. a After a single crossover event of the plasmid with the dut locus, 
the KO construct would lead to the generation of two truncated inactive copies of the gene. b The KOkon plasmid should generate a functional 
copy of the dut gene and a non‑functional pseudogene upon single crossover recombination. c Southern blot analysis of the pHH1‑dutKO 
transfected line after drug cycles. Genomic DNA of the cell line transfected with pHH1‑dutKOk after two (lane 1) and three (lane 2) cycles of drug 
pressure, genomic DNA of the 3D7 parental line (lane 3) and 5 ng of purified plasmid DNA (lane 4) were digested with NdeI. The 1.8 kb band 
corresponding to the endogenous locus is present in the three genomic DNAs, whereas the episome (5.4 kb) is present only in lanes 1 and 2. 
d Southern blot analysis of the pHH1‑dutKOkon transfected line after drug cycles. Genomic DNA of the 3D7 parental line (lane 1), the cell line 
transfected with pHH1‑dutKOkon after two (lane 2) and three (lane 3) cycles of drug pressure and 5 ng of purified plasmid DNA (lane 4) were 
digested with NdeI. The 1.8 kb band corresponding to the endogenous locus is present in the three genomic DNAs, whereas the episome (5.4 kb) 
is present only in lanes 2 and 3. In lanes 2 and 3, two new extra bands of 2.2 kb and 5 kb were detected; the intensity of the bands increased from 
cycle 2 to cycle 3, corresponding to an enrichment of the culture in parasites with the plasmid integrated in the dut locus
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Subsequently, the IC50 for each cell line with each com-
pound and the fold change relative to the 3D7 IC50 was 
calculated (Fig.  3a). For compound 3, one of the most 
potent dUTPase inhibitors with a Ki of 79 nM, overexpres-
sion resulted in a 3.8-fold reduction in potency in the case 
of PfdUTPase (Fig. 3a) and a 2.3 reduction when overex-
pressing HsdUTPase. In the case of compound 4, IC50 val-
ues were increased 4 and 2.5-fold in the PfdUTPase and 
HsdUTPase overexpressing lines respectively. However, 
IC50s for compounds 1 and 2, exhibited minor changes 
with values ranging between 1.55 and 1.10, suggesting that 
Table 1 Ki values for  Plasmodium and  human dUTPases 
and  IC50s for  intraerythrocytic stages of  Plasmodium 
falciparum 
Values are the average of three independent experiments ± standard errors
Ki PfdUTPase Ki HsdUTPase IC50 Pf3D7
Compound 1 4.73 ± 0.16 μM > 100 μM 0.04 ± 0.01 μM
Compound 2 0.56 ± 0.08 μM 12.24 ± 6.91 μM 0.06 ± 0.01 μM
Compound 3 0.079 ± 0.022 μM > 100 μM 0.12 ± 0.05 μM
Compound 4 0.61 ± 0.07 μM > 100 μM 0.15 ± 0.03 μM
Fig. 2 Analysis of mutants overexpressing PfdUTPase and HsdUTPase. a Immunofluorescence analysis of 3D7 wild‑type cells (upper panels) and 
mutants overexpressing PfdUTPase (middle panels) and HsdUTPase (lower panels). A monoclonal antibody for PfdUTPase and a polyclonal antibody 
for HsdUTPase were used. Images were obtained using a confocal Leica TCS SP5 microscope and show a single optical plane. b Western blot 
analysis indicating the correct overexpression of PfdUTPase (left panel) and HsdUTPase (right panel) in parasites transfected with constructs where 
the coding sequence was cloned into pHH2. Western blotting was performed with polyclonal antibodies raised against PfdUTPase and HsdUTPase 
respectively. Hsp70 was used as loading control
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dUTPase is probably not the major target responsible for 
the anti-malarial effect of these latter analogues. The IC50 
for chloroquine as a reference compound was also deter-
mined in overexpressing mutants. No significant effects 
were denoted indicating that changes in compound sus-
ceptibility are specific to dUTPase inhibitors.
Incubation with dUTPase inhibitors results in decreased 
dTTP and increased dUTP levels
Perturbation of the production of dUMP for dTTP 
biosynthesis by different dUTPase inhibitors was 
monitored by determining dTTP levels in parasites. 
Considering the central role of dUTPase in the pro-
duction of dUMP for dTMP synthesis via thymidylate 
synthase-dihydrofolate reductase, the incubation of P. 
falciparum with dUTPase inhibitors should produce 
a decrease in dTTP and an increase in dUTP pools 
in treated cells thus resulting in an imbalance in the 
dUTP/dTTP ratio.
The levels of intracellular dTTP and dUTP were 
measured using the DNA polymerase based assay in 
Plasmodium cultures incubated with compounds 3 and 
4. Parasites for dUTP and dTTP measurements were 
obtained from highly synchronized cultures in schiz-
ont stage after 20 h of treatment with concentrations of 
compound that corresponded with 1× and 3× the IC50 
concentration. As shown in Fig.  3b both compounds 
induced a significant decrease in dTTP and an increase 
in the dUTP pool at high concentrations further sup-
porting that inhibition of dUTPase has an impact on 
dNTP pools and subsequently on parasite replication.
Fig. 3 Effect of dUTPase inhibitors on cell growth and nucleotide pools. a Resistance induced in Plasmodium cultures by overexpression of 
different dUTPases indicated by the fold change observed in the value of IC50 obtained for transfected Plasmodium falciparum lines overexpressing 
PfdUTPase (PfdUTPase OE) and human dUTPase (HsdUTPase OE) with regard to the parental line 3D7. Chloroquine was used as reference 
compound. b Measurements of the dTTP (left panel) and dUTP pools (right panel) after incubation for 20 h with compounds 3 and 4 at different 
concentrations (IC50 and threefold the IC50). Determinations of IC50 values and nucleotide levels were performed in triplicate and the experiments 
were performed twice. Average values of both experiments are indicated and error bars represent the standard error. The asterisks show significant 
differences calculated by the Student’s t‑test. **p < 0.01
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PfdUTPase is mainly localized in the cytosol and expressed 
in a stage‑dependent manner
Indirect immunofluorescence (Fig. 2a) allowed for quan-
tification of the intracellular distribution of the enzyme. 
In trophozoites the signal can be associated mostly with 
the cytosol although a certain overlap occurs with both 
mitochondria and nuclei. Intracellular localization of 
dUTPase in mutants overexpressing PfdUTPase (Fig. 2a) 
was also analysed and appeared to be similar to what was 
observed in the parental cell line.
Additionally, analysis was performed with a cell line 
overexpressing a Pfdut-GFP fusion protein and live 
cell fluorescence microscopy allowing for direct obser-
vation of dUTPase. In this case MitoTracker Red was 
used for mitochondria visualization and Hoechst33342 
for nuclei. As shown in Fig.  4a, a similar protein dis-
tribution to the one observed using indirect immuno-
fluorescence was obtained. The correct expression of 
the fusion protein was confirmed by Western blot with 
polyclonal anti-PfdUTPase antibody (Fig. 4b). A single 
band of approximately 20 kDa was detected in the 3D7 
parental line, while two bands, one corresponding to 
the native PfdUTPase and a second of approximately 
47  kDa corresponding to the PfdUTPase-GFP fusion 
Fig. 4 Expression and intracellular localization of dUTPase at different stages of the intraerythrocytic cycle. The intracellular localization of dUTPase 
was assessed by live cell fluorescence microscopy of cells overexpressing PfdUTPase fused to GFP. a In vivo microscopy of parasites transfected 
with the plasmid pHH2‑Pfdut‑GFP. Cells were previously stained with Hoechst33342 and Mitotracker for nucleus and mitochondria localization. 
Images were taken with a confocal Leica TCS SP5 microscopy system and show a single optical plane. b Western blotting of extracts of parasites 
overexpressing PfdUTPase‑GFP using a polyclonal anti‑PfdUTPase antibody. A band of approximately 46.5 kDa appears only in transfected 
parasites (PfdUTPase GFP OE), corresponding to the fusion protein dUTPase‑GFP. c Expression of PfdUTPase in 3D7 wild‑type cells throughout the 
intraerythrocytic cycle. Protein extracts of parasites in ring (R), trophozoite (T) and schizont (S) stages were subjected to Western blotting with the 
polyclonal dUTPase antibody. Anti‑Hsp70 was used as loading control
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protein, could be detected in pHH2-Pfdut-GFP trans-
fected parasites.
Finally, Western blotting allowed for quantification 
with ImageQuant software (GE healthcare) during the 
life cycle using extracts of highly synchronized 3D7 
wild-type parasites and showed that PfdUTPase levels in 
trophozoites and schizonts (3D7 cells) were 3.3 and 3.8 
times respectively those observed in ring forms (Fig. 4c).
Discussion
Nucleotide metabolism has been highlighted as a source 
of enzymes for target‐based drug development in Plas-
modium [25]. Plasmodium falciparum dUTPase had 
been extensively studied in the search of potent inhibi-
tors showing anti-malarial properties [7, 8, 10] yet, while 
presumed to be indispensable for growth considering its 
central role in providing dUMP for thymidylate biosyn-
thesis, its essential character has not been demonstrated. 
Trimeric dUTPases have been shown to be essential for 
viability in several organisms, such as Saccharomyces cer-
evisiae [5], Escherichia coli [6], or Mycobacterium smeg-
matis [26]. Likewise, knockout mutants for the dimeric 
enzymes present a growth defective phenotype [27]. The 
loss of viability has been associated with an imbalance in 
the dUTP/dTTP ratio. Thus in the absence of dUTPase 
an increase in this ratio results in massive incorpora-
tion of uracil during replication due to an expansion of 
the dUTP pool. Indeed Saccharomyces cerevisiae [5] and 
Trypanosoma brucei [28] knockout mutants are thymi-
dine auxotrophs. Human and Plasmodium dUTPases 
share a similar overall fold yet selective inhibition has 
been shown to be feasible. Thus, a series of trityl and 
deoxyuridine derivatives and their acyclic analogues can 
inhibit P. falciparum dUTPase and show anti-malarial 
activity [8]. Structural data obtained for enzyme–inhibi-
tor complexes evidenced that the triphenylmethane 
group of these compounds interacts with the side chains 
of residues Phe46 and Ile117 that are part of a hydropho-
bic pocket present in Plasmodium dUTPase different 
from the phosphate binding site [13]. These residues are 
replaced by Val42 and Gly87 in the human enzyme [13]. 
The present study provides genetic evidence suggesting 
that PfdUTPase is indeed indispensable for erythrocytic 
stages of P. falciparum. The dut locus could not be dis-
rupted, yet could be correctly targeted. The inability to 
knockout the gene using a simple crossover strategy has 
been understood as evidence that supports the essenti-
ality of the gene [29]. Alternative strategies such as the 
complementation by HsdUTPase in a KO background 
were not feasible. Several reasons may explain this obser-
vation. Thus, it is possible that levels of human enzyme 
are inadequate to sustain dTMP biosynthesis. In addition, 
the existence of protein–protein interactions specific to 
PfdUTPase and that are essential for parasite viability 
cannot be discarded. In support of the essential character 
of Pfdut, a recent study using transposon mutagenesis has 
defined the mutability and fitness costs for over 87% of P. 
falciparum genes and established 2680 genes as essential 
for optimal growth of asexual blood stages in vitro [30]. 
The coding sequence for PfdUTPase appeared in this 
study as non-mutable. Since the absence of insertions in 
the CDS was considered as an indicator that disruptions 
are lethal, the data is also indicative of Pfdut being essen-
tial [30]. In addition, the enzyme appears to be essential 
in P. berghei since deletion of dUTPase failed after several 
attempts suggesting a crucial role during intraerythro-
cytic development [15].
While multiple studies have shown that PfdUTPase can 
be efficiently inhibited in  vitro and that enzyme inhibi-
tors also exhibit antiplasmodial activity, no study has 
been performed in order to validate that indeed the intra-
cellular target of these compounds is dUTPase. Most 
inhibitors discovered to date are uracil-based compounds 
that interact with the substrate binding site. Specifically, 
5′-tritylated nucleosides are selective inhibitors of the 
P. falciparum enzyme versus the HsdUTPase [31]. Fur-
ther modifications of 5′-tritylated deoxyuridine deriva-
tives gave rise to a generation of acyclic analogues that 
showed a good correlation between enzyme inhibition 
and antiparasitic activity [8, 10].
For chemical validation, different compounds that 
exhibit inhibition of both PfdUTPase and antiplasmodial 
activity were chosen. Mutants overexpressing PfdUT-
Pase or HsdUTPase are expected to confer resistance if 
the enzyme is the primary target. When comparing the 
fold change in IC50 of the different compounds tested, 
the action of compounds 3 and 4 was clearly dependent 
on enzyme levels. Compound 3 is a 3′carbamate and a 
potent inhibitor of Plasmodium dUTPase while com-
pound 4 is an acyclic 3′ urea that appears to be eight-
fold less active against the enzyme than compound 3 
although both share the characteristic of exhibiting a 
bulky carboxybenzene substituent in the 3′ position. Both 
exhibit significant antiplasmodial activity in  vitro and 
are selective versus the human enzyme. The lower abil-
ity of HsdUTPase to counteract the effect of the inhibi-
tor, although still doubling the original IC50, can be due 
to low protein levels or a reduced ability of HsdUTPase 
to substitute the Plasmodium enzyme. While not per-
formed in the present study, overexpression of a catalytic 
mutant would not confer resistance to the inhibitors thus 
reinforcing the concept that dUTPase is the target of 
compounds 3 and 4.
In the case of compounds 1 and 2 (3′ urea derivatives) 
dUTPase inhibition does not appear to relate to the anti-
plasmodial activity. Indeed, the Ki values for PfdUTPase 
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for compounds 1 and 2 are respectively nearly two and 
one orders of magnitude higher than their anti-malarial 
activity in  vitro pointing towards the existence of other 
intracellular targets. Hence, while certain compounds 
clearly involve inhibition of dUTPase as their main tar-
get within the cells, for others additional modes of action 
should be invoked, although these remain to be estab-
lished. The pronounced decrease in dTTP and increase in 
dUTP in treated Plasmodium cultures further reinforces 
the idea that compounds 3 and 4 are acting through inhi-
bition of dUTPase. Depletion of nucleotide pools upon 
incubation with specific inhibitors also underscores not 
only the importance of dUTPase in keeping low levels of 
dUTP, but also its key role in providing dUMP for dTTP 
biosynthesis (Additional file 3).
Conclusion
In summary, here evidence is provided that dUTPase is 
a valuable target to be considered for target-based drug 
design. The information presented will contribute to the 
design of potent PfdUTPase inhibitors with anti-malarial 
activity. The future challenge resides in the identifica-
tion of selective, stable drug-like compounds with potent 
activity that may present features that allow for their use 
in vivo.
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